CJC-1295 WITHOUT DAC 5MG + IPA 5MG
Category
CJC-1295 Ipamorelin blend is a synergistic combination of two complementary peptides available from BioSync Solutions. CJC-1295 without DAC (also known as Modified GRF 1-29) is a GH-releasing peptide (GHRH) analog, while Ipamorelin is a selective GH secretagogue. Together they stimulate natural GH release through complementary pathways, creating larger and more physiological GH pulses than either peptide alone.
This CJC-1295 Ipamorelin pre-blended formulation contains 5mg of each peptide per vial, offering researchers a convenient single-vial solution. CJC-1295 amplifies GH pulses by stimulating GHRH receptors on the pituitary, while Ipamorelin triggers GH release through ghrelin/GHS receptors and suppresses somatostatin. This dual-action mechanism has been shown in research to increase GH output by 2-3 times compared to either compound individually.
Research Applications
- GH pulse amplification studies
- GHRH and ghrelin receptor pathway research
- Metabolic function investigations
- Recovery and tissue composition studies
- Synergistic peptide interaction research
- Pituitary response and GH secretion studies
- IGF-1 elevation mechanism research
Why Researchers Choose BioSync Solutions
Our CJC-1295 Ipamorelin blend is manufactured to the highest standards with third-party HPLC verification confirming ≥98% purity. Every vial is independently HPLC tested confirming purity. We offer same-day Dubai delivery, next-day UAE-wide shipping, and international GCC delivery with temperature-controlled cold-chain packaging to preserve peptide integrity.
- Third-party tested ≥99% HPLC purity
- Pre-blended for research convenience
- UAE-based fast shipping with cold-chain
- Certificate of Analysis included
- Secure cold-chain storage and delivery
- Cash on delivery available in UAE
Product Specifications
- Purity: ≥99% (HPLC verified)
- Form: Lyophilized powder
- Amount: 5mg CJC-1295 (no DAC) + 5mg Ipamorelin per vial
- Molecular Weight: CJC-1295: 3367.9 Da, Ipamorelin: 711.85 Da
- Sequence: CJC-1295: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2
- Storage: Store lyophilized powder at -20°C. Reconstituted solution at 2-8°C.
- Shelf Life: 2 years (lyophilized), 4 weeks (reconstituted)
Reconstitution Guide
Reconstitute the CJC-1295 Ipamorelin blend vial with 2ml bacteriostatic water for concentrations of 2.5mg/ml each peptide. Add water gently along the vial wall, swirl without shaking. Store reconstituted solution at 2-8°C and use within 4 weeks. Research protocols typically use the blend 1-3 times daily via subcutaneous administration.
For research purposes only. Not for human consumption.
Frequently Asked Questions
What is CJC-1295 without DAC + Ipamorelin blend?
CJC-1295 (no DAC) + Ipamorelin is a synergistic combination of two peptides. CJC-1295 is a GHRH (GH-releasing peptide) analog, while Ipamorelin is a selective GH secretagogue. Together, they stimulate natural GH release through complementary mechanisms, making this blend popular in longevity and tissue composition research.
How does CJC-1295 + Ipamorelin work together?
CJC-1295 amplifies the GH pulse by stimulating GHRH receptors, while Ipamorelin triggers GH release through ghrelin/GHS receptors and suppresses somatostatin. This dual-action creates larger, more natural GH pulses than either peptide alone, with a synergistic effect that can increase GH output by 2-3 times.
How to reconstitute CJC-1295 + Ipamorelin 5mg+5mg?
Reconstitute the blend vial with 2ml bacteriostatic water for concentrations of 2.5mg/ml each peptide. Add water gently along the vial wall, swirl without shaking. Store at 2-8°C and use within 4 weeks. Administer subcutaneously, typically before bed or in the morning fasted.
Where to buy CJC-1295 + Ipamorelin in UAE Dubai?
BioSync Solutions offers premium CJC-1295 without DAC 5mg + Ipamorelin 5mg blend with ≥98% HPLC verified purity. We provide same-day Dubai delivery, next-day UAE shipping, and international delivery to GCC countries. All products include Certificate of Analysis and cold-chain packaging.
What is the research serving protocol for CJC-1295 + Ipamorelin?
Research protocols typically use 100-300mcg of each peptide (1:1 ratio) administered 1-3 times daily via subcutaneous administration. Best timing: before bed, morning fasted, or post-workout. CJC-1295 (no DAC) has a half-life of ~30 minutes, Ipamorelin ~2 hours. Studies typically run 8-12 weeks with 4-8 weeks off.
